Tris Pharma
Paul C. is an experienced analytical chemist with a robust background in method development and validation within the pharmaceutical industry. Currently serving as an AR&D Senior Scientist at Tris Pharma since November 2021, Paul previously held the same title at Lannett Company from June 2018 to November 2021. Prior to this, Paul worked at Teva/Actavis Generics from July 2005 to June 2018 as Scientist III, focusing on analytical methods for drug products. Beginning the career as an Analytical Chemist at Alpharma from February 2003 to July 2005, Paul contributed to QC stability analyses and played a pivotal role in software transitions. The career started as a Senior Chemist at G&W Laboratories from September 1998 to February 2003, where responsibilities included testing with various analytical instruments. Paul holds a Master of Science degree in Chemistry from Mississippi State University.
Tris Pharma
1 followers
Tris Pharma, Inc. is one of the top five privately-owned specialty pharmaceutical companies in the U.S. with a focus on the development of pharmaceutical science and technology-based products. Specifically, we are engaged in research, development, manufacturing, and commercialization of both branded products and specialty generic products. We have more than a dozen solid and liquid products in the U.S. market based on our numerous NDAs and ANDAs and a rich and growing portfolio of more than 30 U.S. granted patents. Our commercialization success is driven by internal resources for our pediatric products and by licensing of our non-pediatric products to other companies.